Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001367644-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-27 | 2023-02-23+ | EBS | Kramer Robert | Pres, CEO, Dir | F - Tax | $13.99 | -3,019 | 106.5K | -3% | -$42.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | F | D | 1,428 | $14.30 | 108,115 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |
| 2 | Common | Common Stock | 2023-02-24 | F | D | 1,591 | $13.71 | 106,524 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |